Our aim was to explore whether cytotoxic T lymphocyte antigen-4 (CTLA-4) and interleukin-1 (IL-1) polymorphisms are associated with cervical cancer.
Cervical cancer is a malignant neoplasm arising from cells originating in the cervix uteri. It is the second most common cancer in women worldwide and a major cause of mortality in developing countries [1] . Although its etiology is not fully understood, it has been suggested that cervical cancer results from the interaction between a susceptible genome and various environmental factors.
Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) is a critical down-regulatory molecule, expressed in T cells, that plays a major role in inhibiting T cell activation and peripheral tolerance [2] . It has been suggested that CTLA-4 may play a role in the regulation of self-tolerance by the immune system and in the pathogenesis of cancers and autoimmune disorders [3] . Therefore it is highly likely that defective CTLA-4 expression and function are associated with cancers [4] . More than 100 polymorphisms have been identified in the CTLA-4 gene. Of these, CTLA-4 +49 A/G (rs231775) and −318 C/T (rs5742909) have been studied the most in association with cervical cancer. CTLA-4 +49 A/G causes a threonine-to-alanine change at amino acid 17 of CTLA-4, which may reduce its cell surface expression [5] . Carriers of the CTLA-4 −318 T allele show significantly increased expression of CTLA-4 mRNA and protein [6] .
Interleukin-1 (IL-1) initiates the recruitment of immune cells and inflammation [7] . Interleukin-1A (IL-1A) and interleukin-1B (IL-1B) are pro-inflammatory cytokines that bind to the IL-1 receptor, resulting in signal transduction. IL-1 receptor antagonist (IL-1RN) is a competitive inhibitor that does not elicit intracellular signaling when bound to the same receptor [8] . IL-1RN is a member of the IL-1 cytokine family; it inhibits the activity of IL-1A and IL-1B and modulates the immune response [9] . IL-1RN has a variable number tandem repeat (VNTR) polymorphism in intron 2. IL1RN*2 is associated with increased activity of IL1B, which plays a key role as a pro-inflammatory cytokine [10, 11] . The IL-1B −511 C/T (rs16944) and IL-1RN VNTR polymorphisms have been studied most frequently in relation to cervical cancer.
However, previous studies considering the relations between the CTLA-4 and IL-1 polymorphisms and cervical cancer have produced inconsistent results [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . These inconsistencies may be due to the sample sizes, racial/ethnic differences in allele frequencies, or publication bias [26] . Therefore, in order to overcome the limitations of individual studies, resolve inconsistencies, and reduce the likelihood that random errors are responsible for false-positive or falsenegative associations, we turned to meta-analysis [26] [27] [28] . The aim of the present study was to determine using meta-analysis whether the CTLA-4 and IL-1 polymorphisms are associated with cervical cancer.
Materials and methods
Identification of eligible studies and data extraction. We performed a search of studies that examined the associations between the CTLA-4 and IL-1 polymorphisms and cervical cancer. The MEDLINE and EMBASE citation databases were used to identify articles published up to June 2013 in which these two polymorphisms were analyzed in patients with cervical cancer. We used words and phrases such as 'cytotoxic T lymphocyte associated antigen, ' 'CTLA-4, ' 'interleukin-1, ' 'IL-1, ' 'polymorphism, ' and 'cervical cancer' as Medical Subject Headings (MeSH) and search text. References in studies that were identified were investigated, to find additional studies that were not indexed by MEDLINE or EMBASE. Genetic association studies were also eligible for inclusion if they analyzed the distributions of the CTLA-4 +49 A/G, −318 C/T, IL-1B −511C/T, or IL1-RN VNTR polymorphisms in individuals who had cervical cancer and controls who did not. Inclusion criteria were: (1) case-control study design; (2) original data; and (3) sufficient genotype data to calculate odds ratios (ORs). No language restriction was applied. Exclusion criteria were: (1) overlapping data; (2) inability to ascertain the numbers of null and wild genotypes; (3) family members studied, because analyses that include family members include linkage considerations; and (4) genotype distribution in controls not consistent with Hardy-Weinberg equilibrium, because this suggests the possibility of genotyping errors or bias during control-selection. Information on methods and results was extracted from the original publications by two people working independently. Discrepancies were resolved by consensus or a third person. The following information was extracted from each study: author(s), year of publication, ethnicity of the study population, demographics, and numbers of cases and controls for each genotype of the CTLA-4 +49 A/G, −318 C/T, IL-1B −511C/T, and IL-1RN VNTR polymorphisms. Frequencies of alleles were calculated from the corresponding genotype distributions.
Evaluation of publication bias. Funnel plots are often used to detect publication bias. However, this method requires a range of studies of varying sizes and involves subjective judgments, so we evaluated publication bias using Egger's linear regression test [29] , which measures the asymmetry of the funnel plot using odds ratios on a natural logarithm scale.
Evaluations of statistical association. Chi-square tests were used to determine whether observed frequencies of genotypes conformed to Hardy-Weinberg expectations. Metaanalyses were performed using (1) allelic contrast, (2) contrast of homozygotes, and (3) recessive and (4) dominant models. Point estimates of risks, ORs, and 95% confidence intervals (CIs) were estimated for each study. Cochran's Q-statistic was used to assess within-and between-study variation or heterogeneity. This test assesses the null hypothesis that all studies were evaluating the same effect. I 2 values were used to quantify the effect of heterogeneity. Values of I 2 range between 0% and 100% and represent the proportion of between-study variability that can be attributed to heterogeneity rather than chance [30] . I 2 values of 25%, 50%, and 75% were regarded as low, moderate, and high respectively. The fixed effects model assumes that a genetic factor has the same effect on the risk of cervical cancer across all studies, and that the variations observed between studies are caused by chance alone. The random effects model assumes that different studies show substantial diversity and assesses both within-study sampling error and between-study variation. When study groups are homogeneous, the two models are similar, but if this is not the case the random effects model usually provides wider CIs than the fixed effects model. The random effects model is used in the presence of significant between-study heterogeneity [31] . Statistical manipulations were undertaken using Comprehensive Meta-Analysis software (Biostat, Englewood, NJ, USA).
Results
Studies included in the meta-analysis. Electronic and manual searching identified 30 articles, and 17 of these were selected for a full review based on title and abstract details [12-25, 32, 33] . Two were excluded because one was about a different disease [32] and one was about a different polymorphism [33] ; thus, 15 studies in total met our inclusion criteria. These consisted of 8 studies on the CTLA-4 polymorphism [12] [13] [14] [15] [16] [17] [18] and 7 on the IL-1 polymorphism [19] [20] [21] [22] [23] [24] [25] (Fig. 1) . Studies on the CTLA-4 polymorphism used a total of 2,841 patients and 2,558 controls (5,399 study subjects). Two of the study populations were European, four East Asian, one Indian, and one Arab. The CTLA-4 +49 G/A polymorphism was examined by 5 studies and the CTLA-4 −318 C/T polymorphism by 6.
Studies on the IL-1 polymorphism used a total of 1,327 patients and 1,492 controls (2,819 study subjects). Two of the populations were European, two East Asian, two Indian, and one Arab. The IL-1B −511 C/T and IL-1RN VNTR polymorphisms were examined by 4 studies each. Selected characteristics of the studies we used are summarized in Table 1 .
Meta-analysis of association between CTLA-4 +49 A/G and −318 C/T polymorphisms and cervical cancer. A summary of the findings of our meta-analyses on the association between the CTLA-4 +49 A/G and −318 C/T polymorphisms and cervical cancer is shown in Table 2 . Meta-analysis of the CTLA-4 +49 A/G polymorphism showed a significant Figure 2 ). When all studies were considered, meta-analysis revealed no association between cervical cancer and the CTLA-4 −318 C allele (OR = 1.146, 95% CI 0.698-1.881, p = 0.590; Table 2 ). Stratification by ethnicity indicated no association between No association was found between cervical cancer and the CTLA-4 −318 C/T polymorphism using the recessive model, the dominant model, or homozygote contrast (see Figure 2) .
Meta-analysis of association between IL-1B −511C/T and IL-1RN VNTR polymorphisms and cervical cancer.
Meta-analysis showed a significant association between cervical cancer and the IL-1B −511 T allele when all studies were considered (OR = 1.380, 95% CI 1.048-1.816, p = 0.022). (See Table 3 for the meta-analyses in this section.) An association was also found between cervical cancer and the IL-1B −511 C/T polymorphism using the dominant model or contrast of homozygotes (OR = 1.720, 95% CI 1.336-2.214, p = 2.6 × 10 ). Stratification by ethnicity indicated an association between the IL-1B −511 C/T polymorphism in East Asians, using the dominant model or contrast of homozygotes (OR = 1.622, 95% CI 1.227-2.43 p = 0.001; OR = 1.459, 95% CI 1.017-2.073, p = 0.035; see Figure 3 ). When all studies were considered, meta-analysis revealed a trend of association between cervical cancer and the IL-1RN*2 allele (OR = 1.415, 95% CI 0.984-2.034, p = 0.061). Ethnicity-specific meta-analysis revealed an association between the IL-1RN*2 allele and cervical cancer in Indians, but not in Europeans (OR = 2.154, 95% CI 1.547-2.948, p = 1.6 × 10 
B
Heterogeneity and publication bias. Some heterogeneity was found in the meta-analyses of the CTLA-4 and IL-1B −511 C/T polymorphisms, but no between-study heterogeneity was found for the IL-1RN VNTR polymorphisms. Funnel plots are commonly used to detect publication bias, but in our metaanalyses it was difficult to interpret the funnel plots because the number of studies was relatively small. Publication bias causes a disproportionate number of positive studies, and poses a problem for meta-analyses, but Egger's regression test showed no evidence of publication bias in these meta-analyses (all p-values were greater than 0.1; see Figure 4 ).
Discussion
The multifactorial natures of cervical cancers are well recognized, but genetic factors are considered strong determinants of these diseases, and this has encouraged researchers to search for the genes responsible. CTLA-4 is a member of the same family of cell surface molecules as CD28, and it is also responsible for its involvement in the regulation of T cells [2] . CTLA-4 signaling mediates a negative regulator in both cellular and humoral responses, and mediates antigen-specific apoptosis [34] . Negative signaling via CTLA-4 plays an active role in the regulation of autoreactive T cells, and the disruption of the normal physiologic control provided by CTLA-4 can contribute to the pathogenesis of cancers. CTLA-4 polymorphisms have been found to be associated with cancers as well as several autoimmune disorders [3, 35, 36] . IL-1 is a potent inflammatory cytokine that plays a key role in immune regulation [8] and has been associated with pathogenesis of cancer [37] .
This study addresses the association between the CTLA-4 and IL-1 polymorphisms and cervical cancer. Although our Our finding that the CTLA-4 +49 G allele plays a protective role against the development of cervical cancer is consistent with results from functional studies of the CTLA-4 +49 A/G polymorphism. A G allele at exon-1 +49, which causes a threonine-to-alanine change at amino acid 17, leads to less effective CTLA-4 export to the membrane and enhanced T cell proliferation, reducing CTLA-4 expression [5] . Subjects with the CTLA-4 +49 GG genotype have reduced CTLA-4 expression upon T cell activation [5] . Immune responses mediated by T cells are important in controlling HPV-associated cancer [38] . Reduced CTLA-4 expression or function may be associated with cervical cancer risk. The CTLA-4 +49 GG genotype may decrease susceptibility to persistent human papillomavirus (HPV) infection, thus conferring a protective effect against cervical cancer. The CTLA-4 −318 polymorphism may affect the expression of CTLA-4. The −318T allele is associated with higher levels of promoter activity than the −318C allele [6] . Therefore, the presence of the −318T allele may contribute to up-regulation of the expression of CTLA-4, and consequently represents one mechanism to inhibit excessive immune activity.
The present study supports the view that the changes in CTLA-4 expression due to functional polymorphism in CTLA-4 may increase susceptibility to cervical cancer. However, the result of the meta-analysis of the CTLA-4 −318 C/T polymorphism is not consistent with the results of functional studies of CTLA-4. It may not be uncommon that epidemiologic results disagree with the results of functional studies, because cervical cancer is a complex disease, and multiple genes, genetic backgrounds, and environmental factors contribute to its development.
Polymorphisms in cytokine genes can modify the risk of cervical cancer by influencing the immune response to HPV infection [39] . IL-1 reduces apoptosis by changing the ratio of BCL-2/BAX proteins [40] and may lead to increased p53 mutation load [41] . Therefore, increased levels of IL-1 may play a role in cervical cancer susceptibility. The IL-1 −511 C/T polymorphism has been found to be associated with increased intracellular IL-1B production [42] . IL-1RN regulates IL-1 activity by binding to the IL-1 receptor [43] . It has been suggested that IL1RN*2 may have functional importance, because the IL1RN VNTR contains possible binding sites for transcription factors [10, 11, 43] . The relative levels of IL-1RN and IL-1 may determine whether a proinflammatory response will be initiated and persist or instead be terminated. IL1RN*2 is associated with enhanced IL1B levels [44] , results in the lowest IL1RN/IL1B ratio, and was associated with a heightened proinflammatory immune response [45, 46] .
The results of the meta-analysis of the IL-1B −511 C/T and IL-1RN VNTR polymorphisms are consistent with the results of functional studies of the IL-1 polymorphisms. The present study supports the view that the changes in IL-1 function due to functional polymorphism may increase susceptibility to cervical cancer. However, we cannot rule out the possibility that the −511 C/T polymorphism may be affecting the cancer susceptibility due to its linkage with the other polymorphism at the IL-1 locus, which can directly influence the expression of the IL-1B gene.
Our study has some limitations that require consideration. First, heterogeneity and confounding factors may have distorted the analysis. Analysis of data stratified by age, smoking, parity, or HPV status would have provided more information, but these variables were not available. Second, haplotype analysis might have provided more information and would have been more powerful than single polymorphism analysis. However, meta-analysis of haplotypes was not possible due to inadequate haplotype data. Third, the polymorphisms might be associated with the stage of cervical cancer as well as the subject's susceptibility. However, the small amount of data did not allow us to examine possible associations with the stage of cancer. Fourth, the number of studies was too small to enable us to draw conclusions that hold across all the ethnic groups, and it was too small to enable conclusions on certain specific ethnic groups.
In conclusion, this meta-analysis demonstrates that the CTLA-4 +49 A/G and IL-1B −511 C/T polymorphisms are associated with cervical cancer in East Asians, and the IL-1RN VNTR polymorphism is associated with it in Indians. These findings suggest the need for further investigation of the associations between the CTLA-4 and IL-1 polymorphisms and cervical cancer. In particular, larger studies in populations with different ethnicities are necessary to explore the roles played by these two polymorphisms during the pathogenesis of cervical cancer.
